Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1615-1620
Published online before print July 3, 2003, doi: 10.1161/01.ATV.0000084636.01328.C7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
23/9/1615    most recent
01.ATV.0000084636.01328.C7v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, N.
Right arrow Articles by Graham, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, N.
Right arrow Articles by Graham, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Related Collections
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow CV surgery: aortic and vascular disease
Right arrow CV surgery: other
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1615.)
© 2003 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice

Nuala Murphy; K. Richard Bruckdorfer; David C. Grimsditch; Philip Overend; Martin Vidgeon-Hart; Pieter H.E. Groot; G. Martin Benson; Annette Graham

From the Department of Biochemistry and Molecular Biology (N.M., K.R.B., A.G.), Royal Free and University College Medical School of UCL, London; Atherosclerosis Department (D.C.G., P.H.E.G., G.M.B.), GlaxoSmithKline, Herts; and Statistical Sciences (P.O.) and Neurobiology (M.V.-H.) Departments, GlaxoSmithKline, Essex, UK.

Correspondence to Dr G. Martin Benson, Atherosclerosis Department, GlaxoSmithKline, Gunnels Wood Rd, Stevenage, Herts SG1 2NY, UK. E-mail g_martin_benson{at}gsk.com

Objectives— CC and CXC chemokines are implicated in leukocyte recruitment during development of atherosclerotic lesions, suggesting circulating levels of chemokines may be useful serum markers of atherogenesis. Serum chemokine concentrations were measured in apolipoprotein (apo) E*3 Leiden mice and their nontransgenic littermates and related to the differing rates of atherogenesis in these animals.

Methods and Results— Mice were fed a high-fat, high-cholesterol/cholate (HFC/C) diet for 18 weeks. Circulating levels of JE/monocyte chemotactic protein-1 increased (P<0.05) after 2 to 4 weeks, coincident with development of diet-induced hypercholesterolemia, and remained elevated throughout the study. Circulating KC concentrations increased (P<0.05) after consumption of HFC/C diet; however, unlike JE, serum KC concentrations increased more rapidly in apoE*3 Leiden mice than their nontransgenic littermates. Hepatic expression of JE and KC mRNA were detected by in situ hybridization in all mice fed HFC/C diet. Aortic expression of JE mRNA was seen only in apoE*3 Leiden mice within macrophage-rich atherosclerotic lesions. By contrast, no aortic expression of KC mRNA was detected by in situ hybridization.

Conclusions— Increases in serum chemokine concentrations did not reflect temporal aortic production of these molecules and proved less predictive than serum cholesterol of the markedly different extent of atheroma in apoE*3 Leiden and nontransgenic mice.


Key Words: chemokine • KC • JE • atherosclerosis • mice




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L.-N. Zhang, J. Vincelette, Y. Cheng, U. Mehra, D. Chen, S.-K. Anandan, R. Gless, H. K. Webb, and Y.-X. Wang
Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia
Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1265 - 1270.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
R. Tabibiazar, R. A. Wagner, A. Deng, P. S. Tsao, and T. Quertermous
Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice
Physiol Genomics, April 13, 2006; 25(2): 194 - 202.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. R. Veillard, S. Steffens, F. Burger, G. Pelli, and F. Mach
Differential Expression Patterns of Proinflammatory and Antiinflammatory Mediators During Atherogenesis in Mice
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2339 - 2344.
[Abstract] [Full Text] [PDF]